Valeant's Stock Rises After New $2 Billion Buyback Plan Announced
November 20, 2014 at 12:00 PM EST
Valeant Pharmaceuticals' stock got a midday lift Thursday, after the drugmaker announced a new $2 billion securities repurchase program.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.